Cryoballoon
Device
PENTAX of America, Inc.
Total Payments
$1.2M
Transactions
148
Doctors
12
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $213,663 | 35 | 0 |
| 2019 | $476,530 | 54 | 3 |
| 2018 | $556,753 | 59 | 10 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 120 | 95.2% |
| Consulting Fee | $51,600 | 12 | 4.1% |
| Space rental or facility fees (teaching hospital only) | $7,000 | 1 | 0.6% |
| Food and Beverage | $1,213 | 14 | 0.1% |
| Travel and Lodging | $540.42 | 1 | 0.0% |
Payments by Type
Research
$1.2M
120 transactions
General
$60,354
28 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previously- Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $278,637 | 0 |
| Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE) | PENTAX of America, Inc. | $188,554 | 0 |
| Evaluation of CryoBalloon Focal Ablation System in patients with Barrett's Esophagus (Coldplay 2) | PENTAX of America, Inc. | $161,522 | 0 |
| Nitrous Oxide For Endoscopic Ablation or Refractory Barrett's Esophagus | PENTAX of America, Inc. | $130,750 | 0 |
| COLDPLAY 3: Multi-Center Clinical Study to Evaluate the Coldplay Cryoballoon Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $78,802 | 0 |
| Multi-Center Clinical Study to Evaluate the Coldplay CryoballoonTM Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium (Coldplay 3) | PENTAX of America, Inc. | $70,249 | 0 |
| Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients With Previously Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $67,143 | 0 |
| Coldplay 3: Multicenter Clinical Study to Evaluate the CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previosuly-Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $49,593 | 0 |
| Pilot Study of Nitrous Oxide Cryoballoon Ablation for Eradication of Non-Ampullary Sporadic and Familial Duodenal Adenomas | PENTAX of America, Inc. | $40,000 | 0 |
| Coldplay 3: Multicenter Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $26,689 | 0 |
| Clinical Study to Evaluate the Coldplay CryoBalloonTM Full and Swipe Ablation Systems for the Ablation of Human Esophageal Epithelium | PENTAX of America, Inc. | $21,270 | 0 |
| Prospective Characterization of the Neo-Squamous Epithelial Barrier Following Successful Endoscopic Therapy in Barrett's Esophagus | PENTAX of America, Inc. | $19,500 | 0 |
| Multi-Center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients With Previously Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $13,119 | 0 |
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoballoonTM Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $8,750 | 0 |
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previously-Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $8,000 | 0 |
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previosuly-Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $7,251 | 0 |
| Multi-Center Clinical Study to Evaluate the Coldplay CryoballoonTM Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium (COLDPLAY 3) | PENTAX of America, Inc. | $6,378 | 0 |
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoballoonTM Focal Ablation System for the Treatment of Patients with Previouslt Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $4,100 | 0 |
| Multi-Center Clinical Study to Evaluate the C2 CryoBallon Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $2,500 | 0 |
| Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloon Focal Ablation System for the Treatment of Patients with Previously-Untreated Dysplastic Barrett's Epithelium | PENTAX of America, Inc. | $2,335 | 0 |
Top Doctors Receiving Payments for Cryoballoon
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $1.2M | 121 |
| George Triadafilopoulos | — | Mountain View, CA | $42,900 | 6 |
| , M.D | Gastroenterology | Danville, PA | $3,322 | 2 |
| , MD | Gastroenterology | New Hyde Park, NY | $2,230 | 4 |
| , MD | Gastroenterology | Charleston, SC | $2,000 | 1 |
| , M.D | Gastroenterology | New York, NY | $1,121 | 2 |
| , M.D., PH.D | Gastroenterology | W Roxbury, MA | $540.42 | 1 |
| , MD | Gastroenterology | Philadelphia, PA | $500.00 | 2 |
| , MD | Gastroenterology | Marrero, LA | $180.54 | 2 |
| , MD | Gastroenterology | Marrero, LA | $180.52 | 2 |
| , M.D | Gastroenterology | Baltimore, MD | $139.90 | 2 |
| , MD | Gastroenterology | Kenner, LA | $121.51 | 1 |
| , M.D | Internal Medicine | Daytona Beach, FL | $118.36 | 2 |
Ad
Manufacturing Companies
- PENTAX of America, Inc. $1.2M
Product Information
- Type Device
- Total Payments $1.2M
- Total Doctors 12
- Transactions 148
About Cryoballoon
Cryoballoon is a device associated with $1.2M in payments to 12 healthcare providers, recorded across 148 transactions in the CMS Open Payments database. The primary manufacturer is PENTAX of America, Inc..
Payment data is available from 2018 to 2020. In 2020, $213,663 was paid across 35 transactions to 0 doctors.
The most common payment nature for Cryoballoon is "Unspecified" ($1.2M, 95.2% of total).
Cryoballoon is associated with 20 research studies, including "Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previously- Untreated Dysplastic Barrett's Epithelium" ($278,637).